Target intelligence / Profile preview

Adrenoceptor Alpha 2C (ADRA2C)

Target
ADRA2C
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

The adrenergic receptor alpha-2C (ADRA2C) is a G protein-coupled receptor (GPCR) that belongs to the alpha-2 adrenergic receptor family. It regulates neurotransmitter release and mediates catecholamine-induced inhibition of adenylate cyclase. ADRA2C plays roles in cardiovascular regulation and has implications for neuropsychiatric disorders.

02

Mechanism of action

Catecholamine-induced inhibition of adenylate cyclase via G proteins, leading to decreased cAMP levels within cells; modulation of neurotransmitter release; vasoconstriction.

03

Biological functions

Signal transductionRegulation of neurotransmitter releaseInhibition of adenylate cyclase
04

Disease associations

Cardiovascular diseaseNeuropsychiatric disorders
05

Safety considerations

Potential for cardiovascular side effects due to vasoconstriction modulation.Implications for neuropsychiatric disorders require careful consideration in drug development.
06

Interacting drugs

BMY 7378

11 more in the full profile.

Beyond the preview

Go deeper on Adrenoceptor Alpha 2C (ADRA2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adrenoceptor Alpha 2C (ADRA2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call